{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:50:08Z","timestamp":1792407008413,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The sporozoite stages of malaria parasites are the primary cause of infection of the vertebrate host and are targeted by (experimental) vaccines. Yet, little is known about their susceptibility to chemical intervention. Phenotypic high-throughput screens have not been feasible due to a lack of in vitro systems. Here we tested 78 marketed and experimental antimalarial compounds in miniaturized assays addressing sporozoite viability, gliding motility, hepatocyte traversal, and intrahepatocytic schizogony. None potently interfered with sporozoite viability or motility but ten compounds acted at the level of schizogony with IC50s\u2009&lt;\u2009100\u2009nM. To identify compounds directly targeting sporozoites, we screened 81,000 compounds from the Global Health Diversity and reFRAME libraries in a sporozoite viability assay using a parasite expressing a luciferase reporter driven by the circumsporozoite promoter. The ionophore gramicidin emerged as the single hit from this screening campaign. Its effect on sporozoite viability translated into reduced gliding motility and an inability of sporozoites to invade human primary hepatocytes and develop into hepatic schizonts. While providing proof of concept for a small molecule sporontocidal mode of action, our combined data indicate that liver schizogony is more accessible to chemical intervention by (candidate) antimalarials.<\/jats:p>","DOI":"10.1038\/s42003-023-04599-3","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T15:02:29Z","timestamp":1677164549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Assessment of the drugability of initial malaria infection through miniaturized sporozoite assays and high-throughput screening"],"prefix":"10.1038","volume":"6","author":[{"given":"Marie","family":"Miglianico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M.","family":"Bolscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn W.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin J. M.","family":"Koolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marloes","family":"de Bruijni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deeya S.","family":"Rajagopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kiczun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6425-5577","authenticated-orcid":false,"given":"Brice","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Sauerwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8124-4634","authenticated-orcid":false,"given":"Koen J.","family":"Dechering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"key":"4599_CR1","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0140-6736(13)60024-0","volume":"383","author":"NJ White","year":"2014","unstructured":"White, N. J. et al. Malaria. Lancet 383, 723\u2013735 (2014).","journal-title":"Lancet"},{"key":"4599_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature15535","volume":"526","author":"S Bhatt","year":"2015","unstructured":"Bhatt, S. et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature 526, 207\u2013211 (2015).","journal-title":"Nature"},{"key":"4599_CR3","unstructured":"World Health Organization. World Malaria Report 2021 (WHO, 2021)"},{"key":"4599_CR4","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.3389\/fphar.2022.876282","volume":"13","author":"B Hanboonkunupakarn","year":"2022","unstructured":"Hanboonkunupakarn, B., Tarning, J., Pukrittayakamee, S. & Chotivanich, K. Artemisinin resistance and malaria elimination: where are we now? Front. Pharmacol. 13, 3742 (2022).","journal-title":"Front. Pharmacol."},{"key":"4599_CR5","doi-asserted-by":"publisher","first-page":"17050","DOI":"10.1038\/nrdp.2017.50","volume":"3","author":"MA Phillips","year":"2017","unstructured":"Phillips, M. A. et al. Malaria. Nat. Rev. Dis. Prim. 3, 17050 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"4599_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijpara.2016.09.002","volume":"47","author":"ASP Yang","year":"2017","unstructured":"Yang, A. S. P. & Boddey, J. A. Molecular mechanisms of host cell traversal by malaria sporozoites. Int. J. Parasitol. 47, 129\u2013136 (2017).","journal-title":"Int. J. Parasitol."},{"key":"4599_CR7","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1016\/j.celrep.2017.03.017","volume":"18","author":"ASP Yang","year":"2017","unstructured":"Yang, A. S. P. et al. Cell traversal activity is important for Plasmodium falciparum liver infection in humanized mice. Cell Rep. 18, 3105\u20133116 (2017).","journal-title":"Cell Rep."},{"key":"4599_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-016-1675-x","volume":"16","author":"JN Burrows","year":"2017","unstructured":"Burrows, J. N. et al. New developments in anti-malarial target candidate and product profiles. Malar. J. 16, 26 (2017).","journal-title":"Malar. J."},{"key":"4599_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/bies.10050","volume":"24","author":"MM Mota","year":"2002","unstructured":"Mota, M. M. & Rodriguez, A. Invasion of mammalian host cells by Plasmodium sporozoites. BioEssays 24, 149\u2013156 (2002).","journal-title":"BioEssays"},{"key":"4599_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/QCO.0000000000000393","volume":"30","author":"KE Lyke","year":"2017","unstructured":"Lyke, K. E. Steady progress toward a malaria vaccine. Curr. Opin. Infect. Dis. 30, 463\u2013470 (2017).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"4599_CR11","doi-asserted-by":"publisher","first-page":"e07789","DOI":"10.7554\/eLife.07789","volume":"4","author":"CS Hopp","year":"2015","unstructured":"Hopp, C. S. et al. Longitudinal analysis of Plasmodium sporozoite motility in the dermis reveals component of blood vessel recognition. Elife 4, e07789 (2015).","journal-title":"Elife"},{"key":"4599_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/tropicalmed7040058","volume":"7","author":"JJ Moehrle","year":"2022","unstructured":"Moehrle, J. J. Development of new strategies for malaria chemoprophylaxis: from monoclonal antibodies to long-acting injectable drugs. Trop. Med. Infect. Dis. 7, 58 (2022).","journal-title":"Trop. Med. Infect. Dis."},{"key":"4599_CR13","doi-asserted-by":"publisher","first-page":"e1001169","DOI":"10.1371\/journal.pmed.1001169","volume":"9","author":"M Delves","year":"2012","unstructured":"Delves, M. et al. The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites. PLoS Med. 9, e1001169 (2012).","journal-title":"PLoS Med."},{"key":"4599_CR14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.4269\/ajtmh.2011.10-0285","volume":"84","author":"KR Tan","year":"2011","unstructured":"Tan, K. R., Magill, A. J., Parise, M. E., Arguin, P. M., & Centers for Disease Control and Prevention. Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis. Am. J. Trop. Med. Hyg. 84, 517\u2013531 (2011).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"4599_CR15","doi-asserted-by":"publisher","first-page":"e92587","DOI":"10.1172\/jci.insight.92587","volume":"3","author":"EL Flannery","year":"2018","unstructured":"Flannery, E. L. et al. Assessing drug efficacy against Plasmodium falciparum liver stages in vivo. JCI Insight 3, e92587 (2018).","journal-title":"JCI Insight"},{"key":"4599_CR16","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1172\/JCI62684","volume":"122","author":"AM Vaughan","year":"2012","unstructured":"Vaughan, A. M. et al. Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. J. Clin. Invest. 122, 3618\u20133628 (2012).","journal-title":"J. Clin. Invest."},{"key":"4599_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-13-136","volume":"13","author":"MC Behet","year":"2014","unstructured":"Behet, M. C. et al. Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum. Malar. J. 13, 136 (2014).","journal-title":"Malar. J."},{"key":"4599_CR18","doi-asserted-by":"publisher","first-page":"e0041822","DOI":"10.1128\/aac.00418-22","volume":"66","author":"S Kanatani","year":"2022","unstructured":"Kanatani, S. et al. Screening the pathogen box for inhibition of Plasmodium falciparum sporozoite motility reveals a critical role for kinases in transmission stages. Antimicrob. Agents Chemother. 66, e0041822 (2022).","journal-title":"Antimicrob. Agents Chemother."},{"key":"4599_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0131456","volume":"10","author":"A Boes","year":"2015","unstructured":"Boes, A. et al. Analysis of a multi-component multi-stage malaria vaccine candidate-tackling the cocktail challenge. PLoS ONE 10, 1\u201320 (2015).","journal-title":"PLoS ONE"},{"key":"4599_CR20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/cmdc.201200045","volume":"7","author":"ER Derbyshire","year":"2012","unstructured":"Derbyshire, E. R., Mazitschek, R. & Clardy, J. Characterization of Plasmodium liver stage inhibition by halofuginone. ChemMedChem 7, 844\u2013849 (2012).","journal-title":"ChemMedChem"},{"key":"4599_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-018-2469-0","volume":"17","author":"RG Douglas","year":"2018","unstructured":"Douglas, R. G., Reinig, M., Neale, M. & Frischknecht, F. Screening for potential prophylactics targeting sporozoite motility through the skin. Malar. J. 17, 319 (2018).","journal-title":"Malar. J."},{"key":"4599_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/108705719900400206","volume":"4","author":"JH Zhang","year":"1999","unstructured":"Zhang, J. H., Chung, T. D. Y. & Oldenburg, K. R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4, 67\u201373 (1999).","journal-title":"J. Biomol. Screen."},{"key":"4599_CR23","doi-asserted-by":"crossref","unstructured":"Graumans, W. et al. Plasmodium falciparum gametocyte enrichment in peripheral blood samples by magnetic fractionation: gametocyte yields and possibilities to reuse columns. Am. J. Trop. Med. Hyg. 100, 572\u2013577 (2019).","DOI":"10.4269\/ajtmh.18-0773"},{"key":"4599_CR24","doi-asserted-by":"crossref","unstructured":"Dechering, K. J. et al. Replenishing the malaria drug discovery pipeline: screening and hit evaluation of the MMV Hit Generation Library 1 (HGL1) against asexual blood stage Plasmodium falciparum, using a nano luciferase reporter read-out. SLAS Discov. 27, 337\u2013348 (2022).","DOI":"10.1016\/j.slasd.2022.07.002"},{"key":"4599_CR25","first-page":"1","volume":"31","author":"ASP Yang","year":"2021","unstructured":"Yang, A. S. P. et al. Zonal human hepatocytes are differentially permissive to Plasmodium falciparum malaria parasites. EMBO J. 31, 1\u201312 (2021).","journal-title":"EMBO J."},{"key":"4599_CR26","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/bcp.14219","volume":"86","author":"MF Chughlay","year":"2020","unstructured":"Chughlay, M. F. et al. First\u2010in\u2010human clinical trial to assess the safety, tolerability and pharmacokinetics of P218, a novel candidate for malaria chemoprotection. Br. J. Clin. Pharmacol. 86, 1113\u20131124 (2020).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"4599_CR27","doi-asserted-by":"publisher","first-page":"10750","DOI":"10.1073\/pnas.1810137115","volume":"115","author":"J Janes","year":"2018","unstructured":"Janes, J. et al. The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis. Proc. Natl Acad. Sci. USA 115, 10750\u201310755 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4599_CR28","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1177\/00220345820610050201","volume":"61","author":"C Vadeboncoeur","year":"1982","unstructured":"Vadeboncoeur, C., Proulx, M. & Trahan, L. Effect of gramicidin D on the acidogenic properties of oral streptococci and human dental plaque. J. Dent. Res. 61, 632\u2013635 (1982).","journal-title":"J. Dent. Res."},{"key":"4599_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04221-9","volume":"9","author":"A Roth","year":"2018","unstructured":"Roth, A. et al. A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum. Nat. Commun. 9, 1837 (2018).","journal-title":"Nat. Commun."},{"key":"4599_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/srep03418","volume":"3","author":"WJR Stone","year":"2013","unstructured":"Stone, W. J. R. et al. The relevance and applicability of oocyst prevalence as a read-out for mosquito feeding assays. Sci. Rep. 3, 3418 (2013).","journal-title":"Sci. Rep."},{"key":"4599_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16671-0","volume":"7","author":"KJ Dechering","year":"2017","unstructured":"Dechering, K. J. et al. Modelling mosquito infection at natural parasite densities identifies drugs targeting EF2, PI4K or ATP4 as key candidates for interrupting malaria transmission. Sci. Rep. 7, 17680 (2017).","journal-title":"Sci. Rep."},{"key":"4599_CR32","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/nature01107","volume":"419","author":"L Florens","year":"2002","unstructured":"Florens, L. et al. A proteomic view of the Plasmodium falciparum life cycle. Nature 419, 520\u2013526 (2002).","journal-title":"Nature"},{"key":"4599_CR33","doi-asserted-by":"crossref","unstructured":"Plouffe, D. M. et al. High-throughput assay and discovery of small molecules that interrupt malaria transmission. Cell Host Microbe 19, 114\u2013126 (2016).","DOI":"10.1016\/j.chom.2015.12.001"},{"key":"4599_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.chom.2013.06.005","volume":"14","author":"S March","year":"2013","unstructured":"March, S. et al. A microscale human liver platform that supports the liver stages of Plasmodium falciparum and vivax. Cell Host Microbe 14, 104\u2013115 (2013).","journal-title":"Cell Host Microbe"},{"key":"4599_CR35","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.4269\/ajtmh.20-1165","volume":"104","author":"MF Chughlay","year":"2021","unstructured":"Chughlay, M. F. et al. Chemoprotective antimalarial activity of P218 against Plasmodium falciparum: a randomized, placebo-controlled volunteer infection study. Am. J. Trop. Med. Hyg. 104, 1348 (2021).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"4599_CR36","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/jac\/dkv003","volume":"70","author":"JMM Bolscher","year":"2015","unstructured":"Bolscher, J. M. M. et al. A combination of new screening assays for prioritization of transmission-blocking antimalarials reveals distinct dynamics of marketed and experimental drugs. J. Antimicrob. Chemother. 70, 1357\u20131366 (2015).","journal-title":"J. Antimicrob. Chemother."},{"key":"4599_CR37","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1017\/S003118200005335X","volume":"79","author":"RE Sinden","year":"1979","unstructured":"Sinden, R. E. & Smalley, M. E. Gametocytogenesis of Plasmodium falciparum in vitro: the cell-cycle. Parasitology 79, 277\u2013296 (1979).","journal-title":"Parasitology"},{"key":"4599_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15160","volume":"8","author":"C Miguel-Blanco","year":"2017","unstructured":"Miguel-Blanco, C. et al. Hundreds of dual-stage antimalarial molecules discovered by a functional gametocyte screen. Nat. Commun. 8, 15160 (2017).","journal-title":"Nat. Commun."},{"key":"4599_CR39","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1021\/acsinfecdis.7b00225","volume":"4","author":"LE Boucher","year":"2018","unstructured":"Boucher, L. E., Hopp, C. S., Muthinja, J. M., Frischknecht, F. & Bosch, J. Discovery of Plasmodium (M)TRAP\u2013aldolase interaction stabilizers interfering with sporozoite motility and invasion. ACS Infect. Dis. 4, 620\u2013634 (2018).","journal-title":"ACS Infect. Dis."},{"key":"4599_CR40","doi-asserted-by":"publisher","unstructured":"Trivedi, D. V. et al. A small-molecule myosin inhibitor as a targeted multi-stage antimalarial. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.09.09.507317 (2022).","DOI":"10.1101\/2022.09.09.507317"},{"key":"4599_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04465-5","volume":"9","author":"L Xu","year":"2018","unstructured":"Xu, L. et al. Precision therapeutic targeting of human cancer cell motility. Nat. Commun. 9, 2454 (2018).","journal-title":"Nat. Commun."},{"key":"4599_CR42","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.1128\/AAC.04332-14","volume":"59","author":"S D\u2019Alessandro","year":"2015","unstructured":"D\u2019Alessandro, S. et al. Salinomycin and other ionophores as a new class of antimalarial drugs with transmission-blocking activity. Antimicrob. Agents Chemother. 59, 5135\u20135144 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"4599_CR43","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1128\/AAC.41.3.523","volume":"41","author":"C Gumila","year":"1997","unstructured":"Gumila, C., Ancelin, M. L., Delort, A. M., Jeminet, G. & Vial, H. J. Characterization of the potent in vitro and in vivo antimalarial activities of ionophore compounds. Antimicrob. Agents Chemother. 41, 523\u2013529 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"key":"4599_CR44","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.3382\/ps.2010-00931","volume":"89","author":"HD Chapman","year":"2010","unstructured":"Chapman, H. D., Jeffers, T. K. & Williams, R. B. Forty years of monensin for the control of coccidiosis in poultry. Poult. Sci. 89, 1788\u20131801 (2010).","journal-title":"Poult. Sci."},{"key":"4599_CR45","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.2174\/1568026619666181129125950","volume":"18","author":"H Bharti","year":"2019","unstructured":"Bharti, H., Singal, A., Raza, M., Ghosh, P. C. & Nag, A. Ionophores as potent anti-malarials: a miracle in the making. Curr. Top. Med. Chem. 18, 2029\u20132041 (2019).","journal-title":"Curr. Top. Med. Chem."},{"key":"4599_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0005373","volume":"11","author":"MS Love","year":"2017","unstructured":"Love, M. S. et al. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis. PLoS Negl. Trop. Dis. 11, 1\u201319 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"4599_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1017\/S0031182000062065","volume":"98","author":"T Ponnudurai","year":"1989","unstructured":"Ponnudurai, T. et al. Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes. Parasitology 98, 165\u2013173 (1989).","journal-title":"Parasitology"},{"key":"4599_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep18704","volume":"5","author":"MW Vos","year":"2015","unstructured":"Vos, M. W. et al. A semi-automated luminescence based standard membrane feeding assay identifies novel small molecules that inhibit transmission of malaria parasites by mosquitoes. Sci. Rep. 5, 18704 (2015).","journal-title":"Sci. Rep."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-04599-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-04599-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-04599-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T16:12:05Z","timestamp":1677168725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-04599-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4599"],"URL":"https:\/\/doi.org\/10.1038\/s42003-023-04599-3","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]},"assertion":[{"value":"12 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.W.S. and K.J.D. hold stock in TropIQ Health Sciences B.V. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"216"}}